| A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation BW Ramsey, J Davies, NG McElvaney, E Tullis, SC Bell, P Dřevínek, ... New England Journal of Medicine 365 (18), 1663-1672, 2011 | 2405 | 2011 |
| Expression of therapeutic proteins after delivery of chemically modified mRNA in mice MSD Kormann, G Hasenpusch, MK Aneja, G Nica, AW Flemmer, ... Nature biotechnology 29 (2), 154-157, 2011 | 962 | 2011 |
| The human phenotype ontology in 2021 S Köhler, M Gargano, N Matentzoglu, LC Carmody, D Lewis-Smith, ... Nucleic acids research 49 (D1), D1207-D1217, 2021 | 794 | 2021 |
| Pulmonary surfactant in health and human lung diseases: state of the art M Griese European Respiratory Journal 13 (6), 1455-1476, 1999 | 694 | 1999 |
| Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma D Hartl, B Koller, AT Mehlhorn, D Reinhardt, T Nicolai, DJ Schendel, ... Journal of Allergy and Clinical Immunology 119 (5), 1258-1266, 2007 | 581 | 2007 |
| A genome-wide search for linkage to asthma M Wjst, G Fischer, T Immervoll, M Jung, K Saar, F Rueschendorf, A Reis, ... Genomics 58 (1), 1-8, 1999 | 452 | 1999 |
| Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease D Hartl, P Latzin, P Hordijk, V Marcos, C Rudolph, M Woischnik, ... Nature medicine 13 (12), 1423-1430, 2007 | 392 | 2007 |
| DNAH5 Mutations Are a Common Cause of Primary Ciliary Dyskinesia with Outer Dynein Arm Defects N Hornef, H Olbrich, J Horvath, MA Zariwala, M Fliegauf, NT Loges, ... American journal of respiratory and critical care medicine 174 (2), 120-126, 2006 | 379 | 2006 |
| An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome A Panoskaltsis-Mortari, M Griese, DK Madtes, JA Belperio, IY Haddad, ... American journal of respiratory and critical care medicine 183 (9), 1262-1279, 2011 | 323 | 2011 |
| Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial F Ratjen, C Hug, G Marigowda, S Tian, X Huang, S Stanojevic, CE Milla, ... The lancet Respiratory medicine 5 (7), 557-567, 2017 | 320 | 2017 |
| DYX1C1 is required for axonemal dynein assembly and ciliary motility A Tarkar, NT Loges, CE Slagle, R Francis, GW Dougherty, JV Tamayo, ... Nature genetics 45 (9), 995-1003, 2013 | 311 | 2013 |
| Pulmonary alveolar proteinosis BC Trapnell, K Nakata, F Bonella, I Campo, M Griese, J Hamilton, T Wang, ... Nature Reviews Disease Primers 5 (1), 16, 2019 | 278 | 2019 |
| CXCR2 mediates NADPH oxidase–independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation V Marcos, Z Zhou, AÖ Yildirim, A Bohla, A Hector, L Vitkov, ... Nature medicine 16 (9), 1018-1023, 2010 | 276 | 2010 |
| Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases D Hartl, S Krauss-Etschmann, B Koller, PL Hordijk, TW Kuijpers, ... The Journal of Immunology 181 (11), 8053-8067, 2008 | 274 | 2008 |
| European protocols for the diagnosis and initial treatment of interstitial lung disease in children A Bush, S Cunningham, J De Blic, A Barbato, A Clement, R Epaud, ... Thorax 70 (11), 1078-1084, 2015 | 267 | 2015 |
| Mutations in CCNO result in congenital mucociliary clearance disorder with reduced generation of multiple motile cilia J Wallmeier, DA Al-Mutairi, CT Chen, NT Loges, P Pennekamp, ... Nature genetics 46 (6), 646-651, 2014 | 258 | 2014 |
| Pulmonary TH2 response in Pseudomonas aeruginosa–infected patients with cystic fibrosis D Hartl, M Griese, M Kappler, G Zissel, D Reinhardt, C Rebhan, ... Journal of allergy and clinical immunology 117 (1), 204-211, 2006 | 246 | 2006 |
| α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients M Griese, P Latzin, M Kappler, K Weckerle, T Heinzlmaier, T Bernhardt, ... European respiratory journal 29 (2), 240-250, 2007 | 245 | 2007 |
| Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis K Paul, E Rietschel, M Ballmann, M Griese, D Worlitzsch, J Shute, C Chen, ... American journal of respiratory and critical care medicine 169 (6), 719-725, 2004 | 239 | 2004 |
| Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST) EF McKone, D Borowitz, P Drevinek, M Griese, MW Konstan, ... The lancet Respiratory medicine 2 (11), 902-910, 2014 | 236 | 2014 |
